Literature DB >> 7860172

Risk factors for renal cell carcinoma in Denmark: role of medication and medical history.

A Mellemgaard1, S Niwa, E S Mehl, G Engholm, J K McLaughlin, J H Olsen.   

Abstract

BACKGROUND: Several recent studies of risk factors for renal cell carcinoma have indicated that use of diuretics may increase risk of this cancer. It has also been suggested that use of weak analgesics, which are known to increase risk of cancer of the renal pelvis and ureter, may also be associated with an increased risk of renal cell carcinoma--the most frequent type of kidney cancer.
METHODS: A population-based case-control study was undertaken to investigate the role of diuretics, other anti-hypertensive drugs, analgesics, and medical history in the aetiology of renal cell carcinoma. The study base was the total Danish population, and 368 histologically verified cases and 396 sex- and age-matched controls who were interviewed from February 1989 to May 1992.
RESULTS: Response rates were 76% among cases and 79% among controls. We found no general increase in risk among users of diuretics or analgesics, although women taking loop diuretics and heavy users of acetyl salicylic acid had slightly increased risks. The use of nondiuretic anti-hypertensive medications was associated with decreased risk in women. We found non-significantly increased risks for history of hypertension and other cardiovascular disorders. We also observed elevated risks for urological disorders in both sexes which may be a result of recall bias.
CONCLUSION: This study provides only limited support for the suggested association between risk of renal cell carcinoma and use of diuretics and analgesics. The coexistence of renal cell carcinoma and cardiovascular diseases could be caused by risk factors that are common to these conditions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7860172     DOI: 10.1093/ije/23.5.923

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  19 in total

Review 1.  Aspirin and urologic cancer risk: an update.

Authors:  Cristina Bosetti; Valentina Rosato; Silvano Gallus; Carlo La Vecchia
Journal:  Nat Rev Urol       Date:  2012-01-24       Impact factor: 14.432

2.  [Renal cell carcinoma].

Authors:  A Haferkamp; D Rohde; S C Müller; H Rübben; M Hohenfellner
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

3.  Hypertension and risk of renal cell carcinoma among white and black Americans.

Authors:  Joanne S Colt; Kendra Schwartz; Barry I Graubard; Faith Davis; Julie Ruterbusch; Ralph DiGaetano; Mark Purdue; Nathaniel Rothman; Sholom Wacholder; Wong-Ho Chow
Journal:  Epidemiology       Date:  2011-11       Impact factor: 4.822

Review 4.  Carcinogenicity of antihypertensive therapy.

Authors:  Ehud Grossman; Franz H Messerli; Uri Goldbourt
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

Review 5.  Carcinogenicity of cardiovascular drugs.

Authors:  E Grossman; F H Messerli; U Goldbourt
Journal:  Curr Hypertens Rep       Date:  1999-06       Impact factor: 5.369

6.  Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.

Authors:  Chan Yoon; Hyun-Sik Yang; Inpyo Jeon; Yoosoo Chang; Sang Min Park
Journal:  CMAJ       Date:  2011-08-29       Impact factor: 8.262

7.  Antihypertensive medication use and risk of renal cell carcinoma.

Authors:  Joanne S Colt; Jonathan N Hofmann; Kendra Schwartz; Wong-Ho Chow; Barry I Graubard; Faith Davis; Julie Ruterbusch; Sonja Berndt; Mark P Purdue
Journal:  Cancer Causes Control       Date:  2017-02-21       Impact factor: 2.506

8.  Risk factors for renal cell cancer in a Japanese population.

Authors:  Masakazu Washio; Mitsuru Mori
Journal:  Clin Med Oncol       Date:  2009-06-15

9.  Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies.

Authors:  Toni K Choueiri; Youjin Je; Eunyoung Cho
Journal:  Int J Cancer       Date:  2013-09-23       Impact factor: 7.396

10.  Analgesic use and risk of renal cell carcinoma: A case-control, cohort and meta-analytic assessment.

Authors:  Sara Karami; Sarah E Daughtery; Kendra Schwartz; Faith G Davis; Julie J Ruterbusch; Sholom Wacholder; Barry I Graubard; Sonja I Berndt; Jonathan N Hofmann; Mark P Purdue; Lee E Moore; Joanne S Colt
Journal:  Int J Cancer       Date:  2016-04-09       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.